For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260430:nRSd6366Ca&default-theme=true
RNS Number : 6366C Kropz PLC 30 April 2026
30 April 2026
Kropz plc
("Kropz" or the "Company")
Receipt of Exchange Control Approval,
Admission Date of New Ordinary Shares
and
Total Voting Rights
Kropz plc (AIM: KRPZ), an emerging African phosphate producer, is pleased to
announce that it has received approval from the South African Reserve Bank
("Exchange Control Approval") in relation to Fundraising and Amendment to Loan
Terms as announced on 25 February 2026.
Consequently, the Fundraising is now wholly unconditional.
An application has been made for the 79,776,625 new Ordinary Shares ("New
Ordinary Shares") pursuant to the Fundraising to be admitted to trading on AIM
("Admission"). Dealings in respect of the New Ordinary Shares are expected to
commence on or around 8.00 a.m. on 6 May 2026.
Following Admission, the Company's issued share capital will be 1,647,367,866
Ordinary Shares. This figure of 1,647,367,866 may then be used by
shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information visit www.kropz.com (about:blank) or contact:
Via Tavistock
Kropz Plc
Louis Loubser (CEO) +44 (0) 207 920 3150
Grant Thornton UK LLP Nominated Adviser
Samantha Harrison +44 (0) 20 7383 5100
Harrison Clarke
Ciara Donnelly
Hannam & Partners Broker
Andrew Chubb +44 (0) 20 7907 8500
Tavistock Financial PR & IR (UK)
Nick Elwes +44 (0) 207 920 3150
Jos Simson kropz@tavistock.co.uk
R&A Strategic Communications PR (South Africa)
Charmane Russell +27 (0) 11 880 3924
Marion Brower charmane@rasc.co.za
marion@rasc.co.za
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRIMMBTMTIJBBF
Copyright 2019 Regulatory News Service, all rights reserved